618 POSTER A novel tyrosine kinase inhibitor exhibits significant anti-proliferative/pro-apoptotic effects in non-small cell lung cancer models

T.De La Motte Rouge; Y.Zermati; L.Galluzzi; J.P.Armand; T.Wong; G.Kroemer; J.C.Soria

首页> 外文期刊>European Journal of Cancer Supplements >618 POSTER A novel tyrosine kinase inhibitor exhibits significant anti-proliferative/pro-apoptotic effects in non-small cell lung cancer models

【24h】

618 POSTER A novel tyrosine kinase inhibitor exhibits significant anti-proliferative/pro-apoptotic effects in non-small cell lung cancer models

机译：618海报一种新型的酪氨酸激酶抑制剂在非小细胞肺癌模型中显示出显着的抗增殖/促凋亡作用

获取原文

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2006年第12期|共2页
作者
T.De La Motte Rouge; Y.Zermati; L.Galluzzi; J.P.Armand; T.Wong; G.Kroemer; J.C.Soria;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Non-small cell lung cancer PC-9 cells exhibit increased sensitivity to gemcitabine and vinorelbine upon acquiring resistance to EGFR-tyrosine kinase inhibitors [J] . Hamamoto Junko, Yasuda Hiroyuki, Aizawa Kaito, Oncology letters . 2017,第3aPta2期

机译：非小细胞肺癌PC-9细胞在获取抗EGFR-酪氨酸激酶抑制剂的抗性时表现出对吉西他滨和血管内的敏感性增加
2. 428 POSTER Induction of survivin expression via activation of insulin-like growth factor-1 receptor/epidermal growth factor receptor heterodimer: a novel resistance mechanism of EGFR tyrosine kinase inhibitors in non-small cell lung cancer [J] . F.Morgillo, J.K.Woo, W.K.Hong, European Journal of Cancer Supplements . 2006,第12期

机译：428 POSTER通过激活胰岛素样生长因子-1受体/表皮生长因子受体异二聚体诱导survivin表达：非小细胞肺癌中EGFR酪氨酸激酶抑制剂的新型耐药机制
3. Local microwave ablation with continued EGFR tyrosine kinase inhibitor as a treatment strategy in advanced non-small cell lung cancers that developed extra-central nervous system oligoprogressive disease during EGFR tyrosine kinase inhibitor treatment: A pilot study [J] . Ni Yang, Bi Jingwang, Ye Xin, Medicine. . 2016,第25期

机译：EGFR酪氨酸激酶抑制剂的局部微波消融作为晚期非小细胞肺癌的治疗策略，该晚期非小细胞肺癌在EGFR酪氨酸激酶抑制剂的治疗过程中发展为中枢神经系统寡聚进展性疾病：一项先导研究
4. Association between tumor heterogeneity and progression-free survival in non-small cell lung cancer patients with EGFR mutations undergoing tyrosine kinase inhibitors therapy [C] . Jiangdian Song, Di Dong, Yanqi Huang, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2016

机译：接受酪氨酸激酶抑制剂治疗的EGFR突变非小细胞肺癌患者肿瘤异质性与无进展生存的关系
5. Unanticipated Effects of Tyrosine Kinase Inhibitors on Vitamin D Receptor Expression and Gene Regulation In Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer. [D] . Timberlake, Alexandra F. 2017

机译：酪氨酸激酶抑制剂对表皮生长因子受体突变的非小细胞肺癌中维生素D受体表达和基因调控的意外影响。
6. Non-small cell lung cancer PC-9 cells exhibit increased sensitivity to gemcitabine and vinorelbine upon acquiring resistance to EGFR-tyrosine kinase inhibitors [O] . Junko Hamamoto, Hiroyuki Yasuda, Kaito Aizawa, -1

机译：非小细胞肺癌PC-9细胞在获得对EGFR酪氨酸激酶抑制剂的耐药性后对吉西他滨和长春瑞滨具有更高的敏感性
7. DS-1205b, a novel selective inhibitor of AXL kinase, blocks resistance to EGFR-tyrosine kinase inhibitors in a non-small cell lung cancer xenograft model [O] . Takeshi Jimbo, Mana Hatanaka, Takahiro Komatsu, 2019

机译：DS-1205B，一种XL激酶的新选择性抑制剂，阻断非小细胞肺癌异种移植模型中EGFR-酪氨酸激酶抑制剂的抗性

618 POSTER A novel tyrosine kinase inhibitor exhibits significant anti-proliferative/pro-apoptotic effects in non-small cell lung cancer models

著录项

引文网络

相似文献

相关主题

期刊订阅